Now showing items 1-1 of 1

    • Targeting acute myeloid leukemia by drug-induced c-MYB degradation. 

      Walf-Vorderwülbecke, V; Pearce, K; Brooks, T; Hubank, M; van den Heuvel-Eibrink, MM; Zwaan, CM; Adams, S; Edwards, D; Bartram, J; Samarasinghe, S; Ancliff, P; Khwaja, A; Goulden, N; Williams, G; de Boer, J; Williams, O (2018-04)
      Despite advances in our understanding of the molecular basis for particular subtypes of acute myeloid leukemia (AML), effective therapy remains a challenge for many individuals suffering from this disease. A significant ...